Stephen V Liu, MD (@stephenvliu) 's Twitter Profile
Stephen V Liu, MD

@stephenvliu

Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Host @IASLC Podcast; Chair #DCLung24 #TexasLung25 #HereWeGo #LetsGoBucs

ID: 377425889

linkhttps://www.medstarhealth.org/doctors/stephen-liu-md calendar_today21-09-2011 15:17:53

18,18K Tweet

25,25K Followers

3,3K Following

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

#ASCO24 Dr. donington with an insightful discussion of CheckMate 77T update. Clear benefit of periadjuvant nivolumab - even in multi-station N2 and compelling evidence that the adjuvant nivolumab component is playing a critical role in pts with residual disease.

#ASCO24 Dr. <a href="/jdoningtonmd/">donington</a> with an insightful discussion of CheckMate 77T update. Clear benefit of periadjuvant nivolumab - even in multi-station N2 and compelling evidence that the adjuvant nivolumab component is playing a critical role in pts with residual disease.